AP NEWS

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

September 18, 2018

LOS ANGELES--(BUSINESS WIRE)--Sep 18, 2018--The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc. (“Ampio” or the “Company”) (NYSE:  AMPE ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between December 14, 2017 and August 7, 2018, inclusive (the “Class Period”), are encouraged to contact the firm before October 24, 2018.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at  www.schallfirm.com, or by email at  brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Specifically, Ampio failed to disclose that the FDA would find the Company’s AP-003-C Phase 3 clinical trial inadequate and not well-controlled. Ampio had not sufficiently completed two pivotal clinical trials for Ampion. Based on these facts, the company’s statements were false and misleading throughout the class period. When the market learned the truth about Ampio, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180918006096/en/

CONTACT: The Schall Law Firm

Brian Schall, Esq.

Sherin Mahdavian, Esq.

310-301-3335

info@schallfirm.com

www.schallfirm.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL

SOURCE: The Schall Law Firm

Copyright Business Wire 2018.

PUB: 09/18/2018 04:33 PM/DISC: 09/18/2018 04:33 PM

http://www.businesswire.com/news/home/20180918006096/en

AP RADIO
Update hourly